305 related articles for article (PubMed ID: 34472711)
21. Asf1b, the necessary Asf1 isoform for proliferation, is predictive of outcome in breast cancer.
Corpet A; De Koning L; Toedling J; Savignoni A; Berger F; Lemaître C; O'Sullivan RJ; Karlseder J; Barillot E; Asselain B; Sastre-Garau X; Almouzni G
EMBO J; 2011 Feb; 30(3):480-93. PubMed ID: 21179005
[TBL] [Abstract][Full Text] [Related]
22. Systematic pan-cancer analysis identified neuropilin 1 as an immunological and prognostic biomarker.
Ma X; Zhao Y; Shi C; Jiang H; Liu H; Wang H; Qin X; Wang Y; Han Z
Cell Biochem Funct; 2023 Aug; 41(6):658-675. PubMed ID: 37306257
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive Analysis of
Liu J; Zhu B; Chen J; Cao Y
Anticancer Res; 2023 Oct; 43(10):4491-4509. PubMed ID: 37772558
[TBL] [Abstract][Full Text] [Related]
24. Prognostic and immunological role of Ras-related protein Rap1b in pan-cancer.
Cui G; Wang C; Lin Z; Feng X; Wei M; Miao Z; Sun Z; Wei F
Bioengineered; 2021 Dec; 12(1):4828-4840. PubMed ID: 34346294
[TBL] [Abstract][Full Text] [Related]
25. Pan-cancer analysis of
Wang X; Tang Y; Liu R; Li W; Liu S; Zhou X
Biotechnol Genet Eng Rev; 2023 Mar; ():1-23. PubMed ID: 36989393
[TBL] [Abstract][Full Text] [Related]
26. RecQ mediated genome instability 2 (
Wei W; Ying X; Chen L; Sun Q; Lu X; Xia Y; Xu R; Zhu Z; Zhang D; Tang Q; Li L; Xie J; Yu H
Aging (Albany NY); 2022 May; 14(9):4107-4136. PubMed ID: 35552266
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive analysis reveals XCL2 as a cancer prognosis and immune infiltration-related biomarker.
Chen W; Zou F; Song T; Xia Y; Xing J; Rao T; Zhou X; Ning J; Zhao S; Yu W; Cheng F
Aging (Albany NY); 2023 Oct; 15(21):11891-11917. PubMed ID: 37905956
[TBL] [Abstract][Full Text] [Related]
28. Biological and immunological significance of DLL3 expression in different tumor tissues: a pan-cancer analysis.
Zhang Y; Shang L; Han J; Shen X; Liu H; Yang J; Shi H
Aging (Albany NY); 2023 Apr; 15(9):3427-3441. PubMed ID: 37179118
[TBL] [Abstract][Full Text] [Related]
29. The prognostic and immunological effects of ZBTB7C across cancers: friend or foe?
Chen X; Jiang Z; Wang Z; Jiang Z
Aging (Albany NY); 2021 May; 13(9):12849-12864. PubMed ID: 33946045
[TBL] [Abstract][Full Text] [Related]
30. ASF1B Serves as a Potential Therapeutic Target by Influencing Cell Cycle and Proliferation in Hepatocellular Carcinoma.
Ouyang X; Lv L; Zhao Y; Zhang F; Hu Q; Li Z; Zhu D; Li L
Front Oncol; 2021; 11():801506. PubMed ID: 35087760
[TBL] [Abstract][Full Text] [Related]
31. Prognostic and immune regulating roles of YIF1B in Pan-Cancer: a potential target for both survival and therapy response evaluation.
Liu J; Chen Z; Zhao P; Li W
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32648580
[TBL] [Abstract][Full Text] [Related]
32. Systematic pan-cancer analysis identifies transmembrane protein 158 as a potential therapeutic, prognostic and immunological biomarker.
Li J; Hou H; Sun J; Ding Z; Xu Y; Li G
Funct Integr Genomics; 2023 Mar; 23(2):105. PubMed ID: 36977915
[TBL] [Abstract][Full Text] [Related]
33. Pan-Cancer Analysis of OLFML2B Expression and Its Association With Prognosis and Immune Infiltration.
Hu P; Zhang X; Li Y; Xu L; Qiu H
Front Genet; 2022; 13():882794. PubMed ID: 35873458
[No Abstract] [Full Text] [Related]
34. Elevated expression of
Feng Z; Zhang J; Zheng Y; Wang Q; Min X; Tian T
Per Med; 2021 Mar; 18(2):115-127. PubMed ID: 33576264
[No Abstract] [Full Text] [Related]
35. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
Front Immunol; 2021; 12():781087. PubMed ID: 35069553
[TBL] [Abstract][Full Text] [Related]
36. Glycolytic regulatory enzyme PFKFB3 as a prognostic and tumor microenvironment biomarker in human cancers.
Da Q; Huang L; Huang C; Chen Z; Jiang Z; Huang F; Shen T; Sun L; Yan Z; Ye X; Yi J; Huang Y; Da J; Ren M; Liu J; Wang T; Han Z; Ouyang K
Aging (Albany NY); 2023 May; 15(10):4533-4559. PubMed ID: 37253634
[TBL] [Abstract][Full Text] [Related]
37. An integrated pan-cancer analysis of TFAP4 aberrations and the potential clinical implications for cancer immunity.
Liu JN; Kong XS; Sun P; Wang R; Li W; Chen QF
J Cell Mol Med; 2021 Feb; 25(4):2082-2097. PubMed ID: 33373169
[TBL] [Abstract][Full Text] [Related]
38. The interaction between
Zhang Z; Liu S
Ann Med; 2023 Dec; 55(1):1111-1122. PubMed ID: 36947060
[TBL] [Abstract][Full Text] [Related]
39. Anti-silencing function 1B histone chaperone promotes cell proliferation and migration via activation of the AKT pathway in clear cell renal cell carcinoma.
Jiangqiao Z; Tao Q; Zhongbao C; Xiaoxiong M; Long Z; Jilin Z; Tianyu W
Biochem Biophys Res Commun; 2019 Mar; 511(1):165-172. PubMed ID: 30777326
[TBL] [Abstract][Full Text] [Related]
40. Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysis.
Yang L; Zhang Y; Wang Y; Jiang P; Liu F; Feng N
Front Pharmacol; 2022; 13():938134. PubMed ID: 36210836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
